Log in to your IBTimes Account

close
ID
Password

Second Look: Analysts praise Cott's new strategy



By AP
20 June 2008 @ 02:04 pm EST

NEW YORK - Analysts lauded Cott Corp.'s new strategy announced Thursday under which the soda maker will cut costs and focus on its private-label soda business rather than its own branded drinks.

Related Topic

Get stories by e-mail on this topic.

E-mail:
Quotes
COT 1.12 -0.03
WMT 57.18 -2.55

SYMBOL LOOKUP

The company also said it will combine some executive positions and eliminate other positions to cut costs.

The news led shares to rise 19 percent Thursday. Friday afternoon, the stock slipped 5 cents to $2.94 as the broader market fell.

Late Thursday, CIBC World Markets analyst Kenric S. Tyghe upgraded Cott to "Sector Outperformer" from "Market Weight," saying in a note to investors that the company's direction "finally makes sense."

Deutsche Bank North America analyst Marc Greenberg wrote in client note Friday that the new focus is a step in the right direction, but "success looks far from certain."

Greenberg said Cott must focus on improving its U.S. business and repairing its relationship with Wal-Mart Stores Inc., which cut the amount of shelf space it allocated to Cott-made drinks earlier this year. Cott makes the retailer's Sam's Choice soda brand.

"Revitalizing the U.S. business and pressured Wal-Mart relationship is in our view the critical variable to stabilizing sales and profits," Greenberg said.

Copyright 2008 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

    Click!
  • Rate this article:

Comments

Post Your Comment

You must be an IBTimes member to post a comment. Login | Register


advertisement
More Industries
Dendreon Corp. said Monday that its prostate cancer vaccine candidate Provenge may be on target to meet its main goal in a late-stage clinical trial. The...
Shares of General Motors Corp. plunged to their lowest level in more than 54 years Monday, amid a global sell off that sent the Dow Jones industrials dow...
Drug developer Alpharma said Monday it has agreed to share confidential financial information with King Pharmaceuticals, more than a week after rejecting...

Advertisement
Corporate Website Design

Professional Website Design For Corporate - Get a Free Quote Today

advertisement
 
IBTimes.com Web
Partners
International Business Times© 2008 The Ibtimes Company. All Rights Reserved. Terms of service | Privacy Policy | Advertising | About Us | Contact Us | Archives